Xenetic Biosciences Inc. (XBIO)

AI Score

Unlock

2.79

0.10 (3.53%)

At close: Apr 25, 2025, 3:51 PM

2.79

0.00%

After-hours: Apr 25, 2025, 04:00 PM EDT

Xenetic Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-1.05M	-436.67K	-1.27M	-1.2M	-1.17M	-1.06M	-1.05M	-856.55K	-1.48M	-804.02K	-2.67M	-1.59M	-1.84M	-1.35M	-1.11M	-1.35M	-1.2M	-7.56M	-953.64K	-1.18M	-1.17M	-8.9M	-1.38M	-1.33M	-1.64M	-1.81M	-2.03M	-1.82M	4.45M	-2.26M	-2.92M	-2.87M	-391.33K	-2.47M	-47.77M	-3.57M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	19.09K	7.96K	9.61K	9.47K	9.28K	9.04K	8.75K	8.41K	8.04K	6.28K	7.11K	7.42K	7.49K	7.4K	11.13K	1.46K	3.29K	1.14K	5.68K	5.72K	4.45K	5.32K	6.31K	7.71K	9.2K	9.08K	9.08K	9.08K
Stock-Based Compensation	25.11K	27.54K	42.1K	77.07K	74.58K	70.27K	69.39K	68.85K	118.65K	137.36K	135.87K	119.59K	113.1K	111.13K	109.92K	76.28K	80.78K	110.8K	111.73K	165.6K	122.99K	247.44K	222.58K	260.52K	271.24K	362.27K	386.79K	401.28K	309.32K	324.32K	604.43K	681.34K	584.84K	618.72K	259.18K	640.44K
Other Working Capital	470.56K	-87.27K	-164.34K	51.78K	562.81K	-161.53K	-302.5K	-97.94K	101.93K	-192.25K	276.89K	-265.31K	-39.01K	42.01K	110.79K	-109.73K	52.61K	105.47K	254.03K	-86.45K	-355.85K	477.55K	-238.56K	-536.7K	682.43K	69.64K	-327.99K	-51.89K	44.81K	353.89K	399.01K	-527.28K	-2.54M	6.69K	80.92K	-43.93K
Other Non-Cash Items	n/a	615.56K	n/a	170.16K	333.49K	-126.92K	54.44K	285.64K	469.66K	381.6K	1.3M	486.9K	461.19K	-26.11K	-23K	241.32K	2.92M	3.41M	-143.64K	92.14K	-834.1K	6.38M	26.58K	-26.58K	-14.73K	-38.79K	58.82K	4.92K	-8.08K	-22.33K	-80.56K	-15.35K	421.02K	159.12K	47.2M	1.33M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-381.6K	n/a	n/a	-461.19K	n/a	n/a	n/a	-2.92M	2.92M	n/a	n/a	834.1K	n/a	n/a	-2K	n/a	-15.44K	n/a	n/a	n/a	n/a	n/a	n/a	46.85K	73.8K	-1.71M	3.83K
Change in Working Capital	355.42K	-665.46K	706.77K	-41.31K	303.9K	35.66K	-287.55K	-314.74K	124.23K	-420.57K	492.81K	-623.15K	260.6K	197.34K	261.2K	-257.94K	157.54K	106.61K	-322.3K	5.7K	-637.98K	-149.05K	66.18K	-160.67K	338.56K	-164.78K	-513.25K	-256.2K	87.31K	311.39K	401.03K	2.47M	-5.29M	582.37K	650.46K	-191.65K
Operating Cash Flow	-673.99K	-459.04K	-525.1K	-1.16M	-793.03K	-949.63K	-1.27M	-1.1M	-750.91K	-1.08M	-728.9K	-2.09M	-1.46M	-1.03M	-726.81K	-1.52M	-953.66K	-1.01M	-1.3M	-1M	-1.68M	-2.42M	-1.05M	-1.25M	-1.04M	-1.67M	-2.09M	-1.67M	4.84M	-1.64M	-1.99M	280.81K	-4.62M	-1.03M	-1.36M	-1.77M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.83K	-5.43K	-2.18K	n/a	n/a	-14.61K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-500K	n/a	-500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2K	n/a	22.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-500K	n/a	-500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2K	n/a	22.5K	n/a	n/a	n/a	n/a	-3.83K	-5.43K	-2.18K	n/a	n/a	-14.61K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.26M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.03M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	39.5M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-805K	n/a	n/a	n/a	3.68K	11.45M	n/a	n/a	n/a	n/a	n/a	n/a	1.2K	5.01K	n/a	n/a	n/a	n/a	1.48M	n/a	-125	n/a	n/a	-125	8.46M	1M	-5.42K	n/a
Financial Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-805K	n/a	n/a	n/a	11.45M	11.45M	n/a	n/a	5.43M	n/a	n/a	n/a	1.2K	13.43M	509.00	2.7M	n/a	n/a	1.48M	n/a	125.00	n/a	n/a	125.00	8.46M	1M	-5.42K	3.26M
Net Cash Flow	-673.99K	-459.04K	-525.1K	-1.16M	-793.03K	-949.63K	-1.27M	-1.1M	-750.91K	-1.08M	-1.23M	-2.09M	-1.46M	10.42M	-726.81K	-1.52M	4.47M	-1.01M	-1.3M	-1M	-1.68M	11.01M	-1.05M	1.45M	-1.04M	-1.65M	-608.14K	-1.67M	4.84M	-1.64M	-1.99M	275.38K	3.84M	-28.89K	-1.36M	1.47M
Free Cash Flow	-673.99K	-459.04K	-525.1K	-1.16M	-793.03K	-949.63K	-1.27M	-1.1M	-750.91K	-1.08M	-728.9K	-2.09M	-1.46M	-1.03M	-726.81K	-1.52M	-953.66K	-1.01M	-1.3M	-1M	-1.68M	-2.42M	-1.05M	-1.25M	-1.04M	-1.67M	-2.09M	-1.67M	4.84M	-1.64M	-1.99M	275.38K	-4.63M	-1.03M	-1.36M	-1.79M